Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 30.90
-0.05 (-0.16%)
Apr 28, 2026, 1:30 PM CST
Synmosa Biopharma Revenue
In the year 2025, Synmosa Biopharma had annual revenue of 6.19B TWD with 11.53% growth. Synmosa Biopharma had revenue of 1.59B in the quarter ending December 31, 2025, with 5.33% growth.
Revenue
6.19B
Revenue Growth
+11.53%
P/S Ratio
2.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.19B | 639.71M | 11.53% |
| Dec 31, 2024 | 5.55B | 409.05M | 7.96% |
| Dec 31, 2023 | 5.14B | 754.13M | 17.19% |
| Dec 31, 2022 | 4.39B | 1.15B | 35.59% |
| Dec 31, 2021 | 3.23B | 196.67M | 6.47% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ScinoPharm Taiwan | 3.16B |
| YungShin Global Holding | 8.38B |
| Grape King Bio | 10.25B |
| TTY Biopharm Company | 6.45B |
| Foresee Pharmaceuticals | 431.27M |
| Handa Pharmaceuticals | 1.73B |
| Standard Chemical & Pharmaceutical | 7.02B |
| Alar Pharmaceuticals | 2.75M |